Design Therapeutics, Inc. DSGN Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Design Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Design Therapeutics, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Design Therapeutics, Inc.'s retained earnings?
- Design Therapeutics, Inc. (DSGN) reported retained earnings of -$314.64M in Q1 2026.
- How has Design Therapeutics, Inc.'s retained earnings changed year-over-year?
- Design Therapeutics, Inc.'s retained earnings decreased by 28.5% year-over-year, from -$244.93M to -$314.64M.
- What is the long-term trend for Design Therapeutics, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), Design Therapeutics, Inc.'s retained earnings has grown at a 90.2% compound annual growth rate (CAGR), from -$11.92M to -$297.01M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.